Clinical trial
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
NCT04221490 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
- Lead sponsor
- Edwards Lifesciences
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 6, 2020
- Completion date
- January 31, 2029
- Enrollment
- 228 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, heart valve diseases, tricuspid valve regurgitation